Take a brief eligibility survey to see if CentraSight®, a new treatment for advanced age-related macular degeneration (AMD), might be right for you.
Three steps to take today:
- Call toll-free 1-855-539-0011
- Take a brief eligibility survey about a new treatment for advanced AMD
- Thanks to your phone call, CentraSight will donate $25 to Macular Degeneration Research
*Only one call per household
CentraSight, by VisionCare Ophthalmic Technologies, is a treatment program powered by the only FDA-approved telescope implant for advanced AMD. VisionCare is a proud corporate partner of BrightFocus' Macular Degeneration Research program.
Please consult your physician for personalized medical advice. BrightFocus does not endorse any medical products or therapies.
This content was last updated on: April 19, 2016